News

Senate Confirms NIH & FDA Directors; HHS Restructures to Cut Costs and Improve Efficiency

The Senate has confirmed that Dr. Jay Bhattacharya will lead the NIH and Dr. Marty Makary will lead the FDA. Dr. Bhattacharya is most well-known for his contribution to the Great Barrington Declaration, an open letter criticizing the COVID-19 pandemic response, lockdowns, and mask mandates. After receiving the nomination to lead the NIH, Dr. BhattacharyaContinue reading Senate Confirms NIH & FDA Directors; HHS Restructures to Cut Costs and Improve Efficiency

Related to Senate Confirms NIH & FDA Directors; HHS Restructures to Cut Costs and Improve Efficiency:

Other Headlines

Coronavirus

Yale Study Finds Post-Vaccine Syndrome Shares Symptoms with Long COVID

A preprint study from Yale University researchers examined a condition known as post-vaccination syndrome. The study included 42 individuals with PVS and 22 without. Researchers observed elevated levels of spike proteins in the PVS group for 36 to 709 days because the time that lapsed since the last vaccination varied between participants. It is aContinue reading Yale Study Finds Post-Vaccine Syndrome Shares Symptoms with Long COVID

More news about Coronavirus

Health & Nutrition

FDA Says Heavy Metals and Other Contaminants in Menstrual Products Are “Unlikely to Harm”

This week, an op-ed was published in The Conversation, discussing a lack of transparency regarding the materials used to manufacture tampons and other period products. Studies have shown the presence of endocrine disruptors in period products, including “phthalates, volatile organic compounds, parabens, environmental phenols, fragrance chemicals, dioxins, and dioxin-like compounds,” according to a 2024 study.Continue reading FDA Says Heavy Metals and Other Contaminants in Menstrual Products Are “Unlikely to Harm”

More news about Health & Nutrition

Vaccines

RFK Jr. Halts COVID-19 Oral Vaccine Trial for 90 Days, Ends Flu Vaccine Ad Campaign

HHS Secretary Robert F. Kennedy Jr. paused a clinical trial funded by the Biomedical Advanced Research and Development Authority (BARDA) for a COVID-19 oral vaccine made by Vaxart. Kennedy said, “While it is crucial that the Department [of] Health and Human Services (HHS) support pandemic preparedness, four years of the Biden administration’s failed oversight haveContinue reading RFK Jr. Halts COVID-19 Oral Vaccine Trial for 90 Days, Ends Flu Vaccine Ad Campaign

More news about Vaccines

Science & Tech

23andMe Files for Chapter 11 Bankruptcy; Genetic Data of 15 Million Users at Risk of Sale

The genetic data of 15 million people will soon be for sale as 23andMe has filed for Chapter 11 bankruptcy. The attorneys general for California and New York issued consumer alerts to advise consumers to take action to protect their data. New York AG Rob Bonta said “There’s health insurance companies that are interested inContinue reading 23andMe Files for Chapter 11 Bankruptcy; Genetic Data of 15 Million Users at Risk of Sale

More news about Science & Tech

Environment

Bayer Seeks Capital Raise to Cover Roundup Lawsuit Settlements

Bayer continues to face struggles related to its acquisition of Monsanto and the flagship product Roundup, which currently has 67,000 pending cases alleging the herbicide has caused serious health conditions. So far, Bayer has paid out $10 billion to settle cases and has $5.9 billion set aside to resolve the pending cases. Sources told ReutersContinue reading Bayer Seeks Capital Raise to Cover Roundup Lawsuit Settlements

More news about Environment

Policy

Senate Confirms NIH & FDA Directors; HHS Restructures to Cut Costs and Improve Efficiency

The Senate has confirmed that Dr. Jay Bhattacharya will lead the NIH and Dr. Marty Makary will lead the FDA. Dr. Bhattacharya is most well-known for his contribution to the Great Barrington Declaration, an open letter criticizing the COVID-19 pandemic response, lockdowns, and mask mandates. After receiving the nomination to lead the NIH, Dr. BhattacharyaContinue reading Senate Confirms NIH & FDA Directors; HHS Restructures to Cut Costs and Improve Efficiency

More news about Policy

News Archive

Page 1 of 2